-

Owens & Minor Receives Two Vizient Supplier Awards

Awards honor Owens & Minor’s long-standing commitment to service and performance excellence for Vizient’s nationwide membership of healthcare organizations

RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, a leading global healthcare solutions company, has received two 2022 Supplier Awards from Vizient, Inc., the nation’s largest member-driven healthcare performance improvement company. In recognition of its exemplary performance and service, Owens & Minor received both the Medical/Surgical Supplier Excellence Award, and the Achieve Committed Program Excellence Award for its HALYARD* product brand. The recognitions were announced at the 2022 Vizient Connections Summit held Sept. 19-22.

“Customers are at the heart of everything we do, and we are proud of our long-term, consistent commitment to Vizient’s members,” said Jeff Jochims, Executive Vice President, Chief Operating Officer and President, Products & Healthcare Services, Owens & Minor. “We look forward to continuing our collaboration and empowering their success in delivering excellent patient care.”

The awards honor Vizient-contracted suppliers for their superior service, support, reliability, ethics and integrity in collaboration with Vizient and Vizient members. The Medical/Surgical Supplier Excellence Award honors Owens & Minor for its comprehensive contract access across product and service lines and its commitment to value creation and improving total cost of care. The Achieve Committed Program Excellence Award recognizes Owens & Minor’s HALYARD* product brand for providing exceptional value by helping highly committed Vizient members achieve maximum value in select medical-surgical categories.

“We are pleased to recognize Owens & Minor with both of these awards,” said Simrit Sandhu, Executive Vice President, Vizient. “This is an acknowledgement of their achievements in helping Vizient’s members meet their organizational goals for cost management and supply chain efficiency, as well as their commitment to service excellence.”

To learn more about how Owens & Minor supports healthcare customers through its leading supply chain solutions and proprietary products, visit https://www.owens-minor.com/.

About Owens & Minor

Owens & Minor, Inc. (NYSE: OMI) is a Fortune 500 global healthcare solutions company integrating product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. Owens & Minor drives visibility, control and efficiency for patients, providers and healthcare professionals across the supply chain with proprietary technology and solutions, an extensive product portfolio, an Americas-based manufacturing footprint for personal protective equipment (PPE) and surgical products, as well as a robust portfolio of products and services for patients managing chronic and acute conditions in the home setting. Operating continuously since 1882 from its headquarters in Richmond, Va., Owens & Minor is a 140-year-old company powered by more than 20,000 global teammates. Learn more at https://www.owens-minor.com, follow @Owens_Minor on Twitter and connect on LinkedIn at www.linkedin.com/company/owens-&-minor.

Contacts

Media Relations for Owens & Minor:
Stacy Law
media@owens-minor.com

Owens & Minor, Inc.

NYSE:OMI

Release Summary
Owens & Minor received two Vizient Supplier Awards in recognition of its exemplary performance and service.
Release Versions

Contacts

Media Relations for Owens & Minor:
Stacy Law
media@owens-minor.com

Social Media Profiles
More News From Owens & Minor, Inc.

Accendra Health Reports First Quarter 2026 Financial Results and Announces Comprehensive Balance Sheet Optimization Transaction

RICHMOND, Va.--(BUSINESS WIRE)--Accendra Health, Inc. (NYSE: ACH) today reported financial results for the first quarter ended March 31, 2026, and announced a more than $1.5 billion comprehensive balance sheet optimization transaction with commitments from existing creditors that will strengthen the balance sheet, significantly extend maturities and reduce total leverage. Unless otherwise noted, the results herein reflect the Company’s continuing operations, which represent what was previously...

Accendra Health Announces First Quarter 2026 Earnings Release Date and Conference Call

RICHMOND, Va.--(BUSINESS WIRE)--Accendra Health, Inc. (NYSE: ACH) (the “Company”) plans to release financial results for the first quarter of 2026 on Monday, May 11, 2026, before trading begins on the New York Stock Exchange. The Company will host a conference call for investors and analysts at 8:30 a.m. EDT on the same day. Participants may access the call via the toll-free dial-in number at 1-888-300-2035, or the toll dial-in number at 1-646-517-7437. The conference ID access code is 1058917....

Accendra Health Reports Fourth Quarter 2025 Financial Results

RICHMOND, Va.--(BUSINESS WIRE)--Accendra Health, Inc. (NYSE: ACH) today reported financial results for the fourth quarter ended December 31, 2025. Unless otherwise noted, the results herein reflect the Company’s continuing operations, which primarily represent what was previously the Patient Direct segment and certain functional operations. “We ended the fourth quarter with the completion of the sale of the Products & Healthcare Services (P&HS) business on December 31, 2025, and we are...
Back to Newsroom